Back to Search
Start Over
High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapies
- Source :
- Haematologica, Vol 999, Iss 1 (2025)
- Publication Year :
- 2025
- Publisher :
- Ferrata Storti Foundation, 2025.
-
Abstract
- Not available.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 03906078 and 15928721
- Volume :
- 999
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Haematologica
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.1b64d43d030e42dcabc1a25edb4b278d
- Document Type :
- article
- Full Text :
- https://doi.org/10.3324/haematol.2024.286714